project id: TCGA-SARC; case submitter id: TCGA-K1-A6RU; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.01; age at index: 66; days to birth: -24356; days to death: 711; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1947; age at diagnosis: 24356; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 330.0; icd 10 code: C49.2; last known disease status: not reported; morphology: 8811/3; primary diagnosis: Fibromyxosarcoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: No; tissue or organ of origin: Connective, subcutaneous and other soft tissues of lower limb and hip; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 164; initial weight: 410.0; sample id: 431a0f2f-5cf4-46f5-a32f-60af3851e969; sample submitter id: TCGA-K1-A6RU-01A; portion id: 65747c54-6601-4e52-bb0e-55139ef0ce22; portion submitter id: TCGA-K1-A6RU-01A-11; slide id: e3b00a25-938e-4b1f-88d7-dccb81d7c947; slide submitter id: TCGA-K1-A6RU-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 85.0; section location: TOP;